Associations - HRAS Q61L

BIOMARKER:

HRAS Q61L

Entrez ID:

Related biomarkers:

‹

›

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

HRAS Q61L HRAS Q61L	Squamous Cell Carcinoma of Head and Neck SCCHN	trametinib Sensitive: D – Preclinical trametinib Sensitive : D
HRAS Q61L HRAS Q61L	Squamous Cell Carcinoma of Head and Neck SCCHN	tipifarnib Sensitive: D – Preclinical tipifarnib Sensitive : D
HRAS Q61L HRAS Q61L	Squamous Cell Carcinoma of Head and Neck SCCHN	PF-05212384 Sensitive: D – Preclinical PF-05212384 Sensitive : D
HRAS Q61L HRAS Q61L	Squamous Cell Carcinoma of Head and Neck SCCHN	cetuximab Resistant: D – Preclinical cetuximab Resistant : D